BioCapital Europe
Jan Smeitink, Chief Executive Officer will be attending the BioCapital Europe on 14 March 2019. The event offers VCs and institutional investors unique access to over 250 senior executives from biotech, medtech and diagnostics companies from the Benelux and Europe.
Date
Time
Location
Find more articles
- Khondrion announces publication in Brain of integrated Phase 2b program demonstrating disease-modifying potential of sonlicromanol in primary mitochondrial disease
- Khondrion to Present Promising Advances in Mitochondrial Disease Therapy at Bio-Europe and Investival Showcase Events
- Khondrion to present at Mitocon’s 14th Mitochondrial Disease Conference
- Khondrion appoints Jasper Levink as Chief Financial and Business Officer
- EuroHealth Leaders Magazine interviewed Khondrion’s CEO Jan Smeitink
- Khondrion announces grant of patents in the US and Europe for its lead candidate sonlicromanol, covering the anti-inflammatory effect on mPGES-1
- Khondrion to participate in the 16th Annual Dutch Inborn Error Meeting and the United Mitochondrial Disease Foundation (UMDF) Bench to Bedside seminar
- Khondrion joins the NADIS International Student Training Network
- 2022 – A Year in Review
- Khondrion announces sonlicromanol Phase IIb progress supporting Phase III development in MELAS spectrum disorders
- Patient Perspective: A conversation with Kate Murray – CEO and President, MitoCanada
- Khondrion to participate in World Mitochondria Society’s Targeting Mitochondria 2022 Congress
- Patient Perspective: A conversation with Sean Murray – CEO, The Mito Foundation
- Interview with Tom Pulles, Chief Medical Officer at Khondrion
- Khondrion to participate in mitoNice international congress dedicated to mitochondrial medicine
- Patient Perspective: A conversation with Kasey Woleben – Co-founder, and Sophia Zilber – Board Member, Patient Registry Director, Cure Mito Foundation
- Khondrion appoints Tom Pulles, MD, as Chief Medical Officer
- Patient Perspective: A conversation with Philip Yeske, PhD – Science & Alliance Officer, UMDF
- Patient Perspective: A conversation with Alison Maguire – Head of Research & Finance, The Lily Foundation
- Patient Perspective: A conversation with Kira Mann – Newly appointed IMP Chair
- Khondrion completes enrollment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders
- 2021 – A Year in Review
- Movement disorders in children with primary mitochondrial disease
- A coffee with the Scientific Advisory Board: Prof. Dr. Anu Suomalainen Wartiovaara
- A coffee with the Scientific Advisory Board: Prof. Dr. Shamima Rahman